Poolbeg Pharma PLC (AIM:POLB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
4.400
-0.100 (-2.22%)
May 6, 2026, 4:10 PM GMT

Poolbeg Pharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
322836453048
Market Cap Growth
135.03%-21.44%-21.55%49.59%-36.32%-
Enterprise Value
2418253111-
Last Close Price
0.040.040.070.090.060.10
PB Ratio
3.693.243.833.131.652.10
P/TBV Ratio
4.584.034.683.621.872.26
Net Debt / Equity Ratio
-0.90-0.90-0.84-0.84-0.88-0.93
Net Debt / EBITDA Ratio
1.301.301.312.613.276.78
Quick Ratio
6.176.178.3113.0116.8547.96
Current Ratio
6.176.178.7913.6917.7648.98
Return on Equity (ROE)
-63.72%-63.72%-48.83%-24.00%-22.91%-
Return on Assets (ROA)
-37.12%-37.12%-29.75%-16.87%-14.73%-
Return on Capital Employed (ROCE)
-69.70%-69.70%-65.90%-32.40%-27.20%-13.80%
Earnings Yield
-17.95%-20.42%-16.31%-8.69%-15.49%-6.56%
Buyback Yield / Dilution
-21.17%-21.17%---57.62%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.